These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16764140)

  • 1. Search for cure moves forward despite controversy. Interview by Ho Spencer.
    Faustman D
    Nephrol News Issues; 2006 Jun; 20(7):24, 26. PubMed ID: 16764140
    [No Abstract]   [Full Text] [Related]  

  • 2. Spleen cell research could yield potential cure for type 1 diabetes.
    Dent Today; 2004 Jan; 23(1):38. PubMed ID: 14968992
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
    Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human embryonic stem cell research and the Juvenile Diabetes Research Foundation International - a work in progress.
    Nierras CR; Stallard J; Goldstein RA; Insel R
    Pediatr Diabetes; 2004; 5 Suppl 2():94-8. PubMed ID: 15601380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
    Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity.
    King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson M; Wasserfall C; Herold K; Mordes JP; Rossini AA; Greiner DL
    Ann N Y Acad Sci; 2007 Apr; 1103():90-3. PubMed ID: 17376822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ; Zhou ZG; Su H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedical philanthropy: state of the donation.
    Wadman M
    Nature; 2007 May; 447(7142):248-50. PubMed ID: 17507953
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of type 1 diabetes by NKT cells.
    Novak J; Griseri T; Beaudoin L; Lehuen A
    Int Rev Immunol; 2007; 26(1-2):49-72. PubMed ID: 17454264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
    Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
    Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes.
    Funda DP; Kaas A; Tlaskalová-Hogenová H; Buschard K
    Diabetes Metab Res Rev; 2008; 24(1):59-63. PubMed ID: 17607660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune diabetes mellitus--much progress, but many challenges.
    McDevitt HO; Unanue ER
    Adv Immunol; 2008; 100():1-12. PubMed ID: 19111161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Future therapeutic options and their indications: transplantation and the possibilities of regenerative therapy for diabetes type 1].
    Seissler J
    MMW Fortschr Med; 2008 Oct; 150(44):50-1. PubMed ID: 19024493
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperplastic islets observed in "reversed" NOD mice treated without hematopoietic cells.
    Okubo Y; Shimada A; Kanazawa Y; Shigihara T; Oikawa Y; Imai T; Miyazaki J; Itoh H
    Diabetes Res Clin Pract; 2008 Jan; 79(1):18-23. PubMed ID: 17919765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freedom to fund.
    Aschwanden C
    Cell; 2007 Feb; 128(3):421-3. PubMed ID: 17289559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stem cell research in the study of diabetes].
    Pipeleers D
    Verh K Acad Geneeskd Belg; 2003; 65(5):286-7. PubMed ID: 14671844
    [No Abstract]   [Full Text] [Related]  

  • 20. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice.
    Choi MS; Jung UJ; Yeo J; Kim MJ; Lee MK
    Diabetes Metab Res Rev; 2008; 24(1):74-81. PubMed ID: 17932873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.